Product Code: NIY FDA class 2 21 CFR 866.5660

Autoantibodies, Anti-Soluble Liver Antigen (Sla), Autoimmune Hepatitis

Immunology

The Anti-Soluble Liver Antigen (SLA) Autoantibodies test is an ELISA-based in vitro diagnostic device for the detection of anti-SLA antibodies of the IgG class in human serum, intended to aid in the diagnosis of autoimmune hepatitis and other conditions with elevated anti-SLA antibody levels. It is classified as FDA Class 2 (Special Controls), requiring 510(k) clearance, under product code NIY and regulation 21 CFR 866.5660 in the Immunology specialty. The device is eligible for third-party review and carries no implant or life-sustaining flags.

510(k)s
3
FEI Numbers
5
Registration Numbers
5
Unique Applicants
2
Years Active
11

Research product code NIY in seconds

The Research Assistant summarizes clearances, adverse event trends and regulation context for a product code — and cites every record.

Free to try · every answer cites its records

Basic Information

Product Code
NIY
Device Class
FDA class 2
Regulation Number
866.5660
Medical Specialty
Immunology
Review Panel
IM
Submission Type
1

Device Characteristics

GMP Exempt
Implant
Life Sustain/Support
Third Party
Summary Malfunction Reporting

Definition

ELISA for the detection of anti-SLA (soluble liver antigen) antibody of the IgG class. Intended to aid in the diagnosis of conditions with elevated levels of anti-SLA antibody including autoimmune hepatitis

510(k) Clearance History

Loading...

Related 510(k) Clearances

This FDA classification is associated with 3 510(k) clearances via K numbers.

K Number Device Name
K113439 EUROIMMUN EUROLINE PROFILE AUTOIMMUNE LIVER DISEASE 8AG (IGG)
K112221 EUROIMMUN ANTI-SLA/LP ELISA(LGG)
K021482 QUANTA LITE SLA (SOLUBLE LIVER ANTIGEN) ELISA

FEI Numbers

This FDA classification entry is associated with 5 FEI numbers. Click on an entry to view related FDA registrations.

Registration Numbers

This FDA classification entry is associated with 5 registration numbers. Click on an entry to view related FDA registrations.